Robert J. Gould - Jan 13, 2023 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Interim President & CEO, Director
Signature
/s/ Greg Tourangeau, as attorney-in-fact for Robert J. Gould
Stock symbol
FULC
Transactions as of
Jan 13, 2023
Transactions value $
-$101,490
Form type
4
Date filed
1/13/2023, 05:33 PM
Previous filing
Jun 29, 2022
Next filing
Jun 29, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FULC Common Stock Sale -$101K -6.77K -1.34% $15.00 500K Jan 13, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2022.